Get the Stockscreener App
18.22
0.28%
0.05
After Hours:
17.86
-0.36
-1.98%
Mediwound Ltd stock is traded at $18.22, with a volume of 138.66K.
It is up +0.28% in the last 24 hours and up +2.13% over the past month.
MediWound Ltd is an integrated biopharmaceutical company focused on developing, manufacturing, and commercializing novel therapeutic products to address unmet medical needs in the fields of severe burns, chronic and other hard-to-heal wounds, connective tissue disorders, and other indications. Its first biopharmaceutical product, NexoBrid is an FDA-approved orphan biologic for eschar removal in severe burns that can replace surgical interventions and minimize associated costs and complications. Its other product candidates in different stages of the pipeline include EscharEx for debridement of chronic wounds, and MW005 for the treatment of non-melanoma skin cancer. The company derives a majority of its revenue from the United States and the rest from the EU and other international markets.
See More
Previous Close:
$18.17
Open:
$18.12
24h Volume:
138.66K
Relative Volume:
1.39
Market Cap:
$196.92M
Revenue:
$19.85M
Net Income/Loss:
$-12.75M
P/E Ratio:
-13.20
EPS:
-1.38
Net Cash Flow:
$-21.94M
1W Performance:
+2.88%
1M Performance:
+2.13%
6M Performance:
+11.30%
1Y Performance:
+8.39%
1-Day Range:
$17.72
$18.35
1-Week Range:
$17.34
$18.54
52-Week Range:
$14.14
$22.50
Mediwound Ltd Stock (MDWD) Company Profile
Compare MDWD with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
MDWD
Mediwound Ltd
|
18.22 | 232.97M | 19.85M | -12.75M | -21.94M | -1.38 |
|
VRTX
Vertex Pharmaceuticals Inc
|
407.37 | 104.55B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
464.95 | 60.36B | 2.46B | -319.09M | -52.09M | -2.4669 |
|
REGN
Regeneron Pharmaceuticals Inc
|
557.73 | 59.84B | 14.21B | 4.46B | 3.56B | 39.69 |
|
ARGX
Argen X Se Adr
|
799.56 | 49.07B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ONC
Beone Medicines Ltd Adr
|
327.03 | 35.16B | 4.56B | -176.77M | 225.30M | -1.7177 |
Mediwound Ltd Stock (MDWD) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jun-02-25 | Resumed | Oppenheimer | Outperform |
| May-02-25 | Initiated | Alliance Global Partners | Buy |
| Feb-28-25 | Initiated | Craig Hallum | Buy |
| Jul-16-24 | Reiterated | Maxim Group | Buy |
| Dec-22-22 | Initiated | Maxim Group | Buy |
| Jul-18-22 | Resumed | Oppenheimer | Outperform |
| Sep-23-20 | Initiated | BTIG Research | Buy |
| Nov-28-16 | Initiated | Aegis Capital | Buy |
| Aug-17-16 | Initiated | Wells Fargo | Outperform |
| Apr-16-14 | Initiated | Oppenheimer | Outperform |
View All
Mediwound Ltd Stock (MDWD) Latest News
MediWound Ltd.’s volatility index tracking explainedMarket Sentiment Summary & Long-Term Safe Investment Ideas - newser.com
How to read the order book for MediWound Ltd.Weekly Trend Summary & Risk Managed Investment Strategies - newser.com
MediWound Ltd. stock trend forecastJuly 2025 PostEarnings & Weekly Market Pulse Alerts - newser.com
What does recent volatility data suggest for MediWound Ltd.Trade Volume Summary & Reliable Price Breakout Alerts - newser.com
Brokerages Set MediWound Ltd. (NASDAQ:MDWD) Price Target at $32.25 - Defense World
Custom watchlist performance reports with MediWound Ltd.Portfolio Risk Summary & Long-Term Safe Investment Plans - newser.com
Automated trading signals detected on MediWound Ltd.Jobs Report & Community Consensus Trade Signals - newser.com
Weiss Ratings Reiterates Sell (D-) Rating for MediWound (NASDAQ:MDWD) - MarketBeat
MediWound Ltd. (NASDAQ:MDWD) Given Average Recommendation of "Moderate Buy" by Analysts - MarketBeat
Using AI based signals to follow MediWound Ltd.Portfolio Growth Summary & Weekly Chart Analysis and Trade Guides - newser.com
Does MediWound Ltd. fit your quant trading modelGlobal Markets & Free Reliable Trade Execution Plans - newser.com
Is MediWound Ltd. stock attractive for ETFsInsider Buying & AI Based Buy/Sell Signal Reports - newser.com
Will MediWound Ltd. outperform the marketQuarterly Earnings Summary & AI Powered Buy and Sell Recommendations - newser.com
Is MediWound Ltd. stock poised for growthJuly 2025 Weekly Recap & Weekly Breakout Stock Alerts - newser.com
MediWound (NASDAQ:MDWD) Stock Crosses Above Fifty Day Moving AverageHere's Why - MarketBeat
Latham Advises MediWound on US$30 Million Registered Direct Offering of Ordinary Shares - Latham & Watkins LLP
Is MediWound Ltd. stock recession proofMarket Performance Report & Low Drawdown Momentum Trade Ideas - newser.com
Can MediWound Ltd. stock outperform in 2025 bull market2025 Retail Activity & Low Drawdown Investment Strategies - newser.com
Understanding MediWound Ltd.’s price movementJuly 2025 Summary & Daily Technical Stock Forecast Reports - newser.com
Sector ETF performance correlation with MediWound Ltd.2025 Stock Rankings & Free AI Powered Buy and Sell Recommendations - newser.com
Reviewing MediWound (NASDAQ:MDWD) & Cosmos Health (NASDAQ:COSM) - Defense World
Earnings visualization tools for MediWound Ltd.Portfolio Return Report & High Yield Equity Trading Tips - newser.com
Order flow analysis tools used on MediWound Ltd.July 2025 Outlook & Short-Term High Return Ideas - newser.com
Is MediWound Ltd a good long term investmentSector Performance Review & Maximum Capital Growth - earlytimes.in
Predicting MediWound Ltd. trend using moving averagesCEO Change & Weekly Return Optimization Alerts - newser.com
What MACD signals say about MediWound Ltd.July 2025 Retail & Risk Controlled Stock Pick Alerts - newser.com
MediWound Raises $30 Million Through Share Offering to Boost EscharEx® Initiatives - MSN
MediWound (NASDAQ:MDWD) Research Coverage Started at StockNews.com - 富途牛牛
MediWound announces $30M registered direct offering - Yahoo Finance
Published on: 2025-09-30 04:35:12 - newser.com
Goldman Sachs Group Inc. Cuts Position in MediWound Ltd. $MDWD - Defense World
Mediwound Ltd Stock (MDWD) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.11%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):